136 related articles for article (PubMed ID: 9655193)
1. The effect of hexadecylphosphocholine on the degradation of mitochondrial phospholipids.
Vagina O; Gellerich FN; Ulbrich-Hofmann R
Mol Cell Biochem; 1998 Jun; 183(1-2):169-73. PubMed ID: 9655193
[TBL] [Abstract][Full Text] [Related]
2. The interference effects of hexadecylphosphocholine on proliferation and membrane phospholipid metabolism in human myeloid leukemia cell lines.
Wang YZ; Chang YB; Xing C; Fu D
Int J Tissue React; 1998; 20(3):101-7. PubMed ID: 9894183
[TBL] [Abstract][Full Text] [Related]
3. Hexadecylphosphocholine does not influence phospholipase D and sphingomyelinase activity in human leukemia cells.
Berkovic D; Berkovic K; Binder C; Haase D; Fleer EA
J Exp Ther Oncol; 2002; 2(4):213-8. PubMed ID: 12416025
[TBL] [Abstract][Full Text] [Related]
4. The antitumor phospholipid analog, hexadecylphosphocholine, activates cellular phospholipase D.
Wieder T; Zhang Z; Geilen CC; Orfanos CE; Giuliano AE; Cabot MC
Cancer Lett; 1996 Feb; 100(1-2):71-9. PubMed ID: 8620456
[TBL] [Abstract][Full Text] [Related]
5. Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells.
Berkovic D; Grunwald U; Menzel W; Unger C; Hiddemann W; Fleer EA
Eur J Cancer; 1995 Nov; 31A(12):2080-5. PubMed ID: 8562169
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of hexadecylphosphocholine by high-performance thin-layer chromatography with densitometry.
Rustenbeck I; Lenzen S
J Chromatogr; 1990 Jan; 525(1):85-91. PubMed ID: 2338450
[TBL] [Abstract][Full Text] [Related]
7. Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release.
Lindner LH; Hossann M; Vogeser M; Teichert N; Wachholz K; Eibl H; Hiddemann W; Issels RD
J Control Release; 2008 Jan; 125(2):112-20. PubMed ID: 18022271
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of phospholipase A2 in human leukemia cells by the etherphospholipid analogue hexadecylphosphocholine.
Berkovic D; Lüders S; Goeckenjan M; Hiddemann W; Fleer EA
Biochem Pharmacol; 1997 Jun; 53(11):1725-33. PubMed ID: 9264326
[TBL] [Abstract][Full Text] [Related]
9. Comparison of hexadecylphosphocholine with fish oil as an antitumor agent.
Colombo DT; Tran LK; Speck JJ; Reitz RC
J Lipid Mediat Cell Signal; 1997 Sep; 17(1):47-63. PubMed ID: 9302654
[TBL] [Abstract][Full Text] [Related]
10. Hexadecylphosphocholine causes rapid cell death in canine mammary tumour cells.
Duijsings D; Houweling M; Vaandrager AB; Mol JA; Teerds KJ
Eur J Pharmacol; 2004 Oct; 502(3):185-93. PubMed ID: 15476744
[TBL] [Abstract][Full Text] [Related]
11. Interaction of exogenous phospholipids with rat liver mitochondria: the effect of Ca 2+ ions.
Dobiásová M; Linhart J; Bibr B
Physiol Bohemoslov; 1971; 20(5):489-97. PubMed ID: 4259130
[No Abstract] [Full Text] [Related]
12. Hexadecylphosphocholine inhibits phosphatidylinositol and phosphatidylcholine phospholipase C in human leukemia cells.
Berkovic D; Goeckenjan M; Lüders S; Hiddemann W; Fleer EA
J Exp Ther Oncol; 1996 Sep; 1(5):302-11. PubMed ID: 9414418
[TBL] [Abstract][Full Text] [Related]
13. Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues.
Berkovic D; Haase D; Hiddemann W; Fleer EA
J Exp Ther Oncol; 1996 Nov; 1(6):368-75. PubMed ID: 9414427
[TBL] [Abstract][Full Text] [Related]
14. Changes of intracellular calcium, fatty acids and phospholipids during miltefosine-induced apoptosis monitored by fluorescence- and 13C NMR-spectroscopy.
Henke J; Engelmann J; Kutscher B; Nssner G; Engel J; Voegeli R; Leibfritz D
Anticancer Res; 1999; 19(5B):4027-32. PubMed ID: 10628349
[TBL] [Abstract][Full Text] [Related]
15. Structural requirements of lysophospholipid-regulated mitochondrial Ca2+ transport.
Rustenbeck I; Eibl H; Lenzen S
Biochim Biophys Acta; 1991 Oct; 1069(1):99-109. PubMed ID: 1932054
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Ca2+ ions on phospholipase D interaction with mitochondrial membrane phospholipids].
Rkahimov MM; Almatov KT
Biokhimiia; 1978 Aug; 43(8):1390-403. PubMed ID: 737227
[TBL] [Abstract][Full Text] [Related]
17. Antiinvasive activity of hexadecylphosphocholine in vitro.
Schallier DC; Bruyneel EA; Storme GA; Hilgard P; Mareel MM
Anticancer Res; 1991; 11(3):1285-92. PubMed ID: 1888162
[TBL] [Abstract][Full Text] [Related]
18. Effects of hexadecylphosphocholine on fatty acid metabolism: relation to cytotoxicity.
Goppelt-Struebe M; Winter I
Cancer Chemother Pharmacol; 1995; 35(6):519-26. PubMed ID: 7882461
[TBL] [Abstract][Full Text] [Related]
19. Hexadecylphosphocholine inhibits phosphatidylcholine biosynthesis and the proliferation of HepG2 cells.
Jiménez-López JM; Carrasco MP; Segovia JL; Marco C
Eur J Biochem; 2002 Sep; 269(18):4649-55. PubMed ID: 12230578
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
Berkovic D; Berkovic K; Fleer EA; Eibl H; Unger C
Eur J Cancer; 1994; 30A(4):509-15. PubMed ID: 8018410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
